Occupational Therapy for Age-Related Macular Degeneration
What You Need to Know Before You Apply
What is the purpose of this trial?
The goal of this clinical trial is to learn if education about additional task lighting, enhanced contrast, enlarged print instructions, smart apps and organizational strategies will improve medication management skills. The main questions it aims to answer are:Does additional task lighting, enhanced contrast, enlarged print instructions, smart apps and organizational strategies improve medication management skills, reduce errors and improve functional use of remaining vision for this task?Participants will:Oftentimes, the client is unaware of these strategies which may improve occupational performance during a valued activity. Clients with AMD, DR or Glaucoma who choose to receive the one hour OT service will be provided with 1:1 education regarding the devices and strategies that may improve their ability to perform medication management skills.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It seems to focus on improving how you manage your medications rather than changing them.
Is occupational therapy for low vision safe for humans?
How is occupational therapy for age-related macular degeneration different from other treatments?
Occupational therapy for age-related macular degeneration focuses on improving daily living skills and independence through the use of vision-enhancing devices and adaptive equipment, rather than directly treating the eye condition itself. This approach is unique because it combines practical tools and patient education to help individuals adapt to vision loss, enhancing their quality of life.12678
What data supports the effectiveness of the treatment Occupational Therapy Interventions for Low Vision Care for Age-Related Macular Degeneration?
Research shows that occupational therapy interventions, especially those using a multicomponent approach, are effective in helping older adults with low vision improve their ability to perform daily activities at home. Additionally, combining behavioral activation with low vision rehabilitation has been found to improve visual function in patients with age-related macular degeneration.2391011
Who Is on the Research Team?
Michelle Dowling, OTD
Principal Investigator
MCPHS University
Are You a Good Fit for This Trial?
This trial is for individuals with Age-Related Macular Degeneration (AMD) who are receiving eye care services at the MCPHS School of Optometry in Worcester. Participants will allow their anonymous data to be used for research and are interested in learning how certain strategies might improve their medication management.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive a one-hour occupational therapy session focusing on education about task lighting, enhanced contrast, enlarged print instructions, smart apps, and organizational strategies to improve medication management skills.
Follow-up
Participants are reassessed for the effectiveness of interventions provided, using the MediCog and R-SRAFVP assessment tools.
What Are the Treatments Tested in This Trial?
Interventions
- Occupational Therapy Interventions for Low Vision Care
Occupational Therapy Interventions for Low Vision Care is already approved in United States, Canada, European Union for the following indications:
Find a Clinic Near You
Who Is Running the Clinical Trial?
MCPHS University
Lead Sponsor